This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Stephen M. Hahn, M.D., Commissioner of Food and Drugs

Event Date: 08/17/2020
Location: Denver, CO
Subject: Roundtable with Colorado State, Local, Tribal Public Health Officials: COVID-19 Efforts
FDA Participant/Group: COLIN ROM;
Non FDA Participant/Group: Industry, academia and government

Event Date: 08/18/2020
Location: Salt Lake City, UT
Subject: Roundtable with Utah State, Local, Tribal Public Health Officials: COVID-19 Efforts
FDA Participant/Group: COLIN ROM;
Non FDA Participant/Group: Government

Event Date: 08/19/2020
Location: Virtual
Subject: Food and Drug Administration Alumni Association Board Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Several members of the Food and Drug Alumni Association

Official Name: Amy Abernethy, M.D., Ph.D, Principal Deputy Commissioner

Event Date: 08/17/2020
Location: Virtual
Subject: Duke-Margolis & ADVI Meeting: A Cell Therapies Infrastructure Initiative
FDA Participant/Group: PETER MARKS;
Non FDA Participant/Group: Health care providers, industry, academia, and other stakeholders

Event Date: 08/20/2020
Location: Virtual
Subject: Reagan-Udall Foundation: COVID-19 Evidence Accelerator Collaborative Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Patient groups, health care providers, industry, academia, and other stakeholders

Official Name: Anand Shah, M.D., Deputy Commissioner for Medical and Scientific Affairs

Event Date: 08/20/2020
Location: Webinar
Subject: Alliance for Health Policy - The Brazda Breakfast: Reporting on the Future of Health Care Perspectives on Health Policy
FDA Participant/Group: ANAND SHAH;
Non FDA Participant/Group: Sarah J. Dash (Alliance for Health Policy); Bill Pierce (APCO Worldwide);

Official Name: Anna Abram, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 08/20/2020
Location: Virtual
Subject: Safe Food Coalition Meeting
FDA Participant/Group: Several FDA officials and staff
Non FDA Participant/Group: Representatives from consumer organizations, food producer trade unions, and foodborne illness victim organizations

Event Date: 08/20/2020
Location: Virtual
Subject: U.S. Apple Association Outlook 2020 Conference
FDA Participant/Group: MARK MOORMAN;
Non FDA Participant/Group: Leaders from across the apple industry, including production, packing, processing, sales, marketing, and new product development

Official Name: Lowell Schiller, Principal Associate Commissioner for Policy

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: John Wagner, Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Acting Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

No Significant Event

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

Event Date: 08/18/2020
Location: Virtual
Subject: National Center for Toxicological Research Science Advisory Board
FDA Participant/Group: Several FDA officials and staff
Non FDA Participant/Group: N/A

Official Name: Stacy Cline Amin, Chief Counsel

No Significant Event